Published in Headache on March 01, 1983
Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br J Pharmacol (2001) 0.87
BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache. Br J Pharmacol (2009) 0.83
Stress induced delay of ovulation. Obstet Gynecol (1973) 1.57
The effects of sublingual estradiol on left ventricular function at rest and exercise in postmenopausal women: an echocardiographic assessment. Menopause (1998) 1.44
Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts. Eur J Neurol (2011) 1.42
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol (1997) 1.22
Is the fat breath test effective in the diagnosis of fat malabsorption and pancreatic disease? Digestion (1978) 1.15
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler (2011) 0.93
Cytosolic free calcium levels in cultured pituitary cells separated by centrifugal elutriation: effect of gonadotropin-releasing hormone. Endocrinology (1987) 0.91
Serum gonadotrophin levels in pro-oestrous rats in relation to the resumption of meiosis by the oocytes. J Reprod Fertil (1972) 0.91
Paradoxical hypersecretion of growth hormone in patients with endometrial atypical hyperplasia and carcinoma. Effect of hysterectomy. Gynecol Obstet Invest (1982) 0.87
Under-responsiveness of growth hormone secretion after L-dopa and deep sleep stimulation in obese subjects. Isr J Med Sci (1975) 0.87
Use of CA-125 response to predict survival parameters of patients with advanced ovarian carcinoma. Acta Obstet Gynecol Scand (1994) 0.86
Effect of guanine nucleotides on phospholipase C activity in permeabilized pituitary cells: possible involvement of an inhibitory GTP-binding protein. Biochem Biophys Res Commun (1989) 0.83
Suppressive activity of alveolar macrophages and blood monocytes from interstitial lung diseases: role of released soluble factors. Int J Immunopharmacol (1989) 0.83
Gonadotropin-releasing hormone-induced rise in cytosolic free Ca2+ levels: mobilization of cellular and extracellular Ca2+ pools and relationship to gonadotropin secretion. Mol Endocrinol (1988) 0.82
The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS). J Neuroimmunol (2000) 0.82
Acute effects of 17 beta-estradiol on the rat heart. Am J Obstet Gynecol (1994) 0.82
Correlation between PGE2 production and suppressor activity of alveolar macrophages from patients with interstitial lung diseases. Immunol Lett (1988) 0.82
Acute effect of delta1-tetrahydrocannabinol on the hypothalamo-pituitary-ovarian axis in the rat. Neuroendocrinology (1977) 0.81
Kleine-Levin syndrome with periodic apnea during hypersomnic stages--E.E.G. study. J Neural Transm (1978) 0.81
The enigma of parkinsonism in chronic borderline mercury intoxication, resolved by challenge with penicillamine. Neurotoxicology (1996) 0.81
Identification in Israel of 2 Jewish Creutzfeld-Jakob disease patients with a 178 mutation at their PrP gene. Acta Neurol Scand (1998) 0.81
Menopause-induced changes in Doppler-derived parameters of aortic flow in healthy women. Am J Cardiol (1992) 0.81
Letter: Suppression of the cyclic surge of luteinizing hormone secretion and of ovulation in the rat by delta 1-tetrahydrocannabinol. Nature (1973) 0.80
L-tryptophan administration in L-dopa-induced hallucinations in elderly Parkinsonian patients. Gerontology (1977) 0.80
The cholyl glycine-1-14C breath test in various gastrointestinal disorders. Digestion (1979) 0.80
Impulsive artistic creativity as a presentation of transient cognitive alterations. Behav Med (1991) 0.80
The measurement of progesterone in serum by a non-competitive idiometric assay. Steroids (1995) 0.79
Clinical use of high concentration oxytocin drip. Obstet Gynecol (1971) 0.79
Effects of long-term treatment with bromocriptine on pituitary prolactinoma in a male. Int J Gynaecol Obstet (1982) 0.79
Digital road mapping image--a novel fluoroscopic real-time guide for selective transcervical catheterization in the treatment of proximal tubal obstruction. Fertil Steril (1992) 0.78
Suppressive action of norethisterone enanthate and acetate on gonadotropin. (FSH and LH) levels. Radioimmunoassay in eugonadal and postmenopausal women. Obstet Gynecol (1970) 0.78
Microangiopathic hemolytic anemia in severe pre-eclampsia. A review of the literature and pathophysiology. Am J Obstet Gynecol (1974) 0.78
EEG sleep study in parkinsonian patients under bromocryptine treatment. Eur Neurol (1978) 0.78
Receptors for gonadotropin releasing hormone are present in rat oocytes. Endocrinology (1988) 0.78
Menopause-induced changes in left ventricular wall thickness. Am J Cardiol (1993) 0.78
Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients: an open-label 2-year follow-up. J Neurol Sci (2002) 0.78
Experimental extension of the time interval between oocyte maturation and ovulation: effect on fertilization and first cleavage. Fertil Steril (1995) 0.78
Another look at co-treatment with growth hormone and human menopausal gonadotrophins in poor ovarian responders. Hum Reprod (1993) 0.78
Effect of estradiol on rat ileum. Gen Pharmacol (1998) 0.77
L-thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism. Gynecol Endocrinol (1999) 0.77
[Dextran-40 in nonhemorrhagic cerebrovascular accidents]. Harefuah (1981) 0.77
IVF-ET in women with refractory polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol (1989) 0.77
The effect of various hormonal preparations and calcium supplementation on bone mass in early menopause. Is there a predictive value for the initial bone density and body weight? J Intern Med (1999) 0.77
The effect of the hypoestrogenic state, induced by gonadotropin-releasing hormone agonist, on Doppler-derived parameters of aortic flow. J Clin Endocrinol Metab (1993) 0.77
Late hypoglycemia in patients following vagotomy and pyloroplasty. Int Surg (1974) 0.77
Menopause-related changes in left ventricular function in healthy women. Cardiology (1992) 0.76
Measurement of prostaglandin E2 in cerebrospinal fluid in patients suffering from stroke. J Neurol Neurosurg Psychiatry (1977) 0.76
Periodic lateralized epileptiform discharges in multiple sclerosis: a case report. J Clin Neurophysiol (2003) 0.76
EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study. J Neural Transm (1979) 0.76
Responsiveness of the human fetus to stress. Isr J Med Sci (1974) 0.76
The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome. Clin Endocrinol (Oxf) (1979) 0.76
Immunoreactive insulin in serum and seminal plasma of diabetic and nondiabetic men and its role in the regulation of spermatozoal activity. Fertil Steril (1977) 0.76
Weight loss in patients treated long-term with levodopa. Metabolic aspects. J Neurol Sci (1976) 0.75
Acute polyneuropathy combined with myasthenia gravis. Acta Neurol Scand (1982) 0.75
Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study. J Neurol (1978) 0.75
Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading. J Neural Transm (1979) 0.75
Serum myoglobin in detection of myocardial necrosis in patients with "coronary insufficiency". Clin Cardiol (1987) 0.75
Antigenic components of rat connective tissue. 3. Liver connective tissue antigens of rats made cirrhotic by treatment with carbon tetrachloride. Br J Exp Pathol (1968) 0.75
Hormone-replacement therapy compared with simvastatin for postmenopausal women with hypercholesterolemia. N Engl J Med (1998) 0.75
Pure red cell aplasia responsive to interferon-alpha in a patient with hepatitis C virus infection. Acta Haematol (1998) 0.75
Calcium homeostasis, bone metabolism and safety aspects during long-term treatment with a GnRH agonist. Maturitas (1992) 0.75
[Unusual causes of stroke in young patients]. Harefuah (1978) 0.75
[Transvaginal fallopian tubal catheterization: clinical applications and limitations]. Harefuah (1992) 0.75
Thymectomy and chronic relapsing experimental allergic encephalomyelitis in guinea pigs. Arch Neurol (1984) 0.75
Changes in prostate-specific markers under chronic gonadotrophin-releasing hormone analogue treatment of state D prostatic cancer. Cancer (1989) 0.75
In vitro presynaptic modulation of cholinergic hippocampal activity by pituitary-adrenocortical hormones. Exp Neurol (1987) 0.75
Sonographic monitoring of ovarian volume during LHRH analogue therapy in women with polycystic ovarian syndrome. J Ultrasound Med (1988) 0.75
[Basilar artery migraine]. Schweiz Med Wochenschr (1980) 0.75
Hormone replacement and simvastatin in the therapy of hypercholesterolemic postmenopausal women. J Med (1998) 0.75
[Effect of bromocriptine on secretion of the enzyme dopamine-B-hydroxylase (DBH) in patients with Parkinson's disease]. Riv Neurol (1980) 0.75
Oligoclonal IgG bands in the CSF of a patient with progressive familial myoclonus. Eur Neurol (1985) 0.75
R.H.I.S.A. -- cysternography study in sporadic choreo-athetotic syndrome accompanied with dementia (sporadic Huntington disease). Riv Patol Nerv Ment (1981) 0.75
[Herpes simplex infection--a venero-neuro-genital disease]. Harefuah (1978) 0.75
Organic depression. Isr Ann Psychiatr Relat Discip (1979) 0.75
Pregnancy outcome in luteinizing hormone-releasing hormone induced cycles: a multicentre study. Gynecol Endocrinol (1989) 0.75
Combined transvaginal tubal catheterization and adhesiolysis of filmy uterine synechiae performed with a newly developed device under the guidance of digital road mapping fluoroscopy. Fertil Steril (1993) 0.75
[Lithium carbonate in Huntington's disease]. Harefuah (1978) 0.75
Acute embolic bilateral renal artery occlusions in an elderly patient--case report: importance of early diagnosis. Gerontology (1984) 0.75
A case of hypergonadotrophinaemia associated with very high isolated concentrations of immunologically and biologically active luteinizing hormone. Hum Reprod (1996) 0.75
Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension. Am J Cardiol (1996) 0.75
The effects of 17beta-estradiol on ectopic rhythm in human atrial strips. Maturitas (1999) 0.75
Long-term effects of hormone replacement therapy on Doppler-derived parameters of aortic flow in postmenopausal women. Chest (1992) 0.75
The effect of oophorectomy and estrogen replacement therapy on Doppler derived parameters of aortic flow. Maturitas (2000) 0.75
Pregnancy outcome following early exposure to maternal luteinizing-hormone-releasing hormone agonist (buserelin). Hum Reprod (1989) 0.75
Convulsive attacks due to antidepressant drug overdoses: case reports and discussion. Gen Hosp Psychiatry (1983) 0.75
The role of increased prolactin levels under GnRH analogue treatment in advanced prostatic carcinoma. Cancer (1988) 0.75
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats. Acta Neurol Scand (1986) 0.75
Effect of various neuroactive drugs on bromocriptine concentration in the striatum of rats. Isr J Med Sci (1984) 0.75
CSF renin activity in hypertensive and normotensive patients. Schweiz Arch Neurol Neurochir Psychiatr (1981) 0.75
L-dopa effect on prolactin plasma levels in complicated and common migrainous patients. Headache (1981) 0.75
Is idiopathic atrial fibrillation caused by occult thyrotoxicosis? A study of one hundred consecutive patients with atrial fibrillation. Int J Cardiol (1991) 0.75
Effects of long term treatment with finasteride (MK-906), a 5-alpha reductase inhibitor, on circulating LH, FSH, prolactin and estradiol. Horm Metab Res (1992) 0.75
The behavioral effect of salbutamol (a beta-adrenergic receptor stimulant) on reserpine- and propranolol-treated rats. J Neurol (1983) 0.75
Blood-C.S.F. barriers dysfunction in the chronic organic brain syndrome; a R.I.A. study. Schweiz Arch Neurol Neurochir Psychiatr (1978) 0.75
Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel). Encephale (1981) 0.75